INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
SJ

Sumner Michael John

Chief Medical OfficerCIK 0001936799

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 0
Max Insider Score21
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
46.9K sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    INOVIO PHARMACEUTICALS, INC.Chief Medical Officer · Mar 5, 2026
13
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Tax withholding
F
$3,312
2,693 sh
May 20, 2026
May 21, 2026
traded May 20, 2026
+1d
SEC FORM 4

Evidence

21
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
9,450 sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
37.7K sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

17
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
9,450 sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

13
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
4,292 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Tax withholding
F$2,128
1,223 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
4,292 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
36.8K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
29.6K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence